BioCentury
ARTICLE | Financial News

Atomwise JV raises $14.5M series A to advance AI-discovered candidates

November 15, 2019 12:02 AM UTC

X-37 raised a $14.5 million series A to move forward AI platform-generated programs from Atomwise, which launched the JV last year with Velocity Pharmaceutical Development.

DCVC Bio led Thursday’s round, with participation from Alpha Intelligence Capital and Hemi Ventures. ...